{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:40:21Z","timestamp":1780605621647,"version":"3.54.1"},"reference-count":14,"publisher":"e-Century Publishing Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Physiol Pathophysiol Pharmacol"],"DOI":"10.62347\/zytu1875","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T04:49:01Z","timestamp":1751863741000},"page":"99-103","source":"Crossref","is-referenced-by-count":1,"title":["Ischemic cardiomyopathy in a 43-year-old male with stroke during admission: the role of chronic amphetamine-dextroamphetamine use"],"prefix":"10.62347","volume":"17","author":[{"given":"AmirBehzad","family":"Bagheri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"7722","DOI":"10.3390\/ijms22147722","article-title":"Cardiomyopathies: an overview","volume":"22","author":"Ciarambino","year":"2021","unstructured":"Ciarambino T, Menna G, Sansone G and Giordano M. Cardiomyopathies: an overview. Int J Mol Sci 2021; 22: 7722.","journal-title":"Int J Mol Sci"},{"key":"ref1","unstructured":"Cregin D, Koltun R, Malik S, Umeozor D and Begdache L. The adderall epidemic: a proposed cyclic relationship between ADHD medication use, academic performance, and mental distress. Impulse 2021; 18."},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Torres-Acosta N, O’Keefe JH, O’Keefe CL and Lavie CJ. Cardiovascular effects of ADHD therapies: JACC review topic of the week. J Am Coll Cardiol 2020; 76: 858-866.","DOI":"10.1016\/j.jacc.2020.05.081"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Reddy PKV, Ng TMH, Oh EE, Moady G and Elkayam U. Clinical characteristics and management of methamphetamine-associated cardiomyopathy: state-of-the-art review. J Am Heart Assoc 2020; 9: e016704.","DOI":"10.1161\/JAHA.120.016704"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40256-022-00523-y","article-title":"A comprehensive approach to managing methamphetamine-associated cardiomyopathy","volume":"22","author":"Osekowski","year":"2022","unstructured":"Osekowski M, Trytell A, La Gerche A, Prior D, MacIsaac A and Paratz ED. A comprehensive approach to managing methamphetamine-associated cardiomyopathy. Am J Cardiovasc Drugs 2022; 22: 385-393.","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.62347\/JGQA3746","article-title":"Exploring the seas for cancer cures: the promise of marine-derived bioactive peptide","volume":"15","author":"Rafieezadeh","year":"2024","unstructured":"Rafieezadeh D and Abbaspour M. Exploring the seas for cancer cures: the promise of marine-derived bioactive peptide. Int J Biochem Mol Biol 2024; 15: 100-106.","journal-title":"Int J Biochem Mol Biol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s10741-022-10261-7","article-title":"Cardiovascular disease associated with methamphetamine use: a review","volume":"27","author":"Tobolski","year":"2022","unstructured":"Tobolski J, Sawyer DB, Song SJ and Afari ME. Cardiovascular disease associated with methamphetamine use: a review. Heart Fail Rev 2022; 27: 2059-2065.","journal-title":"Heart Fail Rev"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Rose CJ, Klein MW and Hama Amin A. A hyperactive heart: a case of adderall-induced cardiomyopathy. Circulation 2023; 148 Suppl 1: A12588-A12588.","DOI":"10.1161\/circ.148.suppl_1.12588"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Lewars JT and Wiarda KP. Amphetamine-dextroamphetamine-induced cardiomyopathy, an emerging cause of heart failure in young patient populations: a case study involving the study drug. Cureus 2023; 15: e40942.","DOI":"10.7759\/cureus.40942"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.62347\/AUPQ6330","article-title":"Extracellular vesicles and their therapeutic applications: a review article (part 2)","volume":"16","author":"Rafieezadeh","year":"2024","unstructured":"Rafieezadeh D. Extracellular vesicles and their therapeutic applications: a review article (part 2). Int J Physiol Pathophysiol Pharmacol 2024; 16: 81-88.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1161\/ATVBAHA.119.312461","article-title":"Methamphetamine use and cardiovascular disease","volume":"39","author":"Kevil","year":"2019","unstructured":"Kevil CG, Goeders NE, Woolard MD, Bhuiyan MS, Dominic P, Kolluru GK, Arnold CL, Traylor JG and Orr AW. Methamphetamine use and cardiovascular disease. Arterioscler Thromb Vasc Biol 2019; 39: 1739-1746.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1038\/s41598-024-53470-w","article-title":"Amphetamine increases vascular permeability by modulating endothelial actin cytoskeleton and NO synthase via PAR-1 and VEGF-R","volume":"14","author":"B&#xF6","year":"2024","unstructured":"Böttner J, Fischer-Schaepmann T, Werner S, Knauth S, Jahnke HG, Thiele H and Büttner P. Amphetamine increases vascular permeability by modulating endothelial actin cytoskeleton and NO synthase via PAR-1 and VEGF-R. Sci Rep 2024; 14: 3596.","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Habeb B, Demirag N and Retzloff J. Prolonged amphetamine-dextroamphetamine use: an unrecognized cause of cardiomyopathy. Cureus 2025; 17: e80553.","DOI":"10.7759\/cureus.80553"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Al-Juhani A, Alyaseen EM, Aseri S, Alghamdi OM and Alghamdi O. Amphetamine-dextroamphetamine-induced cardiomyopathy: a case report on heart failure in a young addict. Cureus 2024; 16: e71044.","DOI":"10.7759\/cureus.71044"}],"container-title":["International Journal of Physiology, Pathophysiology and Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ijppp\/17\/3\/ijppp0165334.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:55:45Z","timestamp":1766022945000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ijppp\/17\/3\/ijppp0165334.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":14,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/zytu1875","relation":{},"ISSN":["1944-8171"],"issn-type":[{"value":"1944-8171","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}